Pfizer submits data seeking U.S. approval of COVID vaccine for young kids: Bloomberg
WASHINGTON — Pfizer Inc on Tuesday began submitting data to federal regulators as part of the process to win U.S. approval of its COVID-19 vaccine for children under age 5, …
Read More